📰 16 sources covering this story

Eli Lilly takes aim at illicit market for its experimental weight-loss drug

First covered 2 days ago · latest take 35 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Eli Lilly takes aim at illicit market for its experimental weight-loss drug
CBS News
CBS News35 mins ago
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
London law student died in halls of residence after taking weight loss drug, inquest hears
Josephine Nasr, 19, had been prescribed Zepbound which doctors think triggered a fatal heart rhythm
RNZ
RNZ7 hrs ago
Toddler died after 'very significant level of force', inquest told
There was no scenario where Sadie-Leigh Gardner was able to sustain her injuries without anyone else involved, says a
The Times
The Times16 hrs ago
Coroner links teenage student’s death to weight-loss drug Mounjaro
Coroner links teenage student’s death to weight-loss drug Mounjaro  The Times
CNBC
CNBC20 hrs ago
Eli Lilly takes weight-loss pill battle global with first Foundayo approval in Europe
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
Quartz
Quartz22 hrs ago
Eli Lilly's weight-loss pill is approved in the U.K.
The U.K. regulator authorized orforglipron for weight management and type 2 diabetes, making Britain the first country in Europe to clear the drug
The Independent
The Independent1 days ago
London law student died in halls of residence after taking weight loss drug, inquest told
Police searched the room and found an empty vial of Tirzepatide, a weight loss drug prescribed in the United States under the name Zepbound and in the UK as Mounjaro
STAT News
STAT News1 days ago
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
'Good news' as new weight loss drug approved for use in UK
The UK is the first country in Europe to approve Foundayo, a new weight loss pill that also treats type 2 diabetes. Find out who is eligible.
NZ Herald
NZ Herald1 days ago
The dangers of taking weight loss drugs after 60
Telegraph: These are the risks to be aware of before starting the medication.
CTV News
CTV News1 days ago
New Alzheimer’s drug recommendation offers hope patients and families
A new recommendation from Canada’s Drug Agency could make an Alzheimer’s treatment more accessible to Canadians in the early stages of the disease.
Reuters
Reuters1 days ago
Eli Lilly's weight-loss pill secures first European nod in Britain
Eli Lilly's weight-loss pill secures first European nod in Britain  Reuters
The Herald
The Herald1 days ago
Weight-loss drugs reshape food and drink spending habits across Scotland
New research suggests GLP-1 weight-loss drugs are changing what Scottish consumers buy, with spending shifting away from snacks and processed foods towards healthier options.
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients - WSJ
Amazon to Offer GLP-1 Weight-Loss Drugs to Medicare Part D Patients  WSJ
New York Post
New York Post🏁 first to report2 days ago
Sudden death of California law student studying abroad linked to popular weight loss shot, inquest heard
Josephine Nasr, 19, died of a cardiac arrhythmia in her room at the University of East London in September 2025, an East London Coroner's Court heard last week.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →